<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Generation of splice variants in the RON receptor tyrosine kinase facilitates the invasive phenotype of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we report a new splice variant of RON in the human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell line HCT116 </plain></SENT>
<SENT sid="2" pm="."><plain>This variant is encoded by a transcript differing from the full-length RON <z:chebi fb="2" ids="33699">mRNA</z:chebi> by an in-frame deletion of 106 amino acids in the extracellular domain of RON β-chain </plain></SENT>
<SENT sid="3" pm="."><plain>The deleted transcript originates by an alternative deletion of exon 2 and exon 3 </plain></SENT>
<SENT sid="4" pm="."><plain>The molecular weight of this variant is 160 kDa </plain></SENT>
<SENT sid="5" pm="."><plain>Thus, we named this variant RONΔ160(E2E3) </plain></SENT>
<SENT sid="6" pm="."><plain>This variant is a single-chain protein and expressed in the intracellular compartment </plain></SENT>
<SENT sid="7" pm="."><plain>We found that RONΔ160(E2E3) had no tyrosine phosphorylation ability, but it has constitutively activated Akt activity in transfected HEK293 epithelial cells </plain></SENT>
<SENT sid="8" pm="."><plain>The expression of this variant in HEK293 cells resulted in an increased migratory activity in vitro mediated through the PI-3K/Akt pathway </plain></SENT>
<SENT sid="9" pm="."><plain>Our data describes a new splice variant of RON and suggests a novel role for the RON receptor in the progression of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>